New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
20:25 EDTPM, PM, SAP, SAP, UNH, UNH, DHR, DHR, BAX, BAX, BHI, BHI, MAS, MASNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Morgan Stanley (MS), consensus 55c; Philip Morris (PM), consensus $1.24; SAP (SAP), consensus 76c; UnitedHealth Group (UNH), consensus $1.26; Danaher (DHR), consensus 94c; Baxter (BAX), consensus $1.22; Baker Hughes (BHI), consensus 90c.
News For MAS;PM;SAP;UNH;DHR;BAX;BHI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 17, 2014
10:35 EDTSAPBlackBerry expands enterprise application portfolio
Subscribe for More Information
10:02 EDTBHIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Google (GOOG) upgraded to Buy from Hold at Pivotal Research... Twitter (TWTR) upgraded to Buy from Hold at Pivotal Research... Aaron's (AAN) upgraded to Buy from Hold at KeyBanc... Calpine (CPN) upgraded to Buy from Hold at Deutsche Bank... Check Point (CHKP) upgraded to Buy from Hold at Deutsche Bank... Columbia Sportswear (COLM) upgraded to Buy from Neutral at Goldman... Dakota Plains Holdings (DAKP) upgraded to Buy from Hold at Canaccord... SunCoke Energy (SXC) upgraded to Outperform from Neutral at Credit Suisse... Taylor Morrison (TMHC) upgraded to Buy from Hold at Evercore ISI... Teck Resources (TCK) upgraded to Buy from Neutral at UBS... VeriFone (PAY) upgraded to Overweight from Equal Weight at Barclays... Motorola Solutions (MSI) upgraded to Buy from Hold at Argus... Approach Resources (AREX) upgraded to Neutral from Reduce at Global Hunter... HealthSouth (HLS) upgraded to Outperform from Market Perform at Raymond James... QLogic (QLGC) upgraded to Overweight from Equal Weight at Morgan Stanley... Baker Hughes (BHI) upgraded to Focus List from Outperform at Howard Weil... Kansas City Southern (KSU) upgraded to Overweight from Equal Weight at Stephens... BlackBerry (BBRY) upgraded to Buy from Hold at BGC Financial.
08:53 EDTBHIBaker Hughes upgraded to Focus List from Outperform at Howard Weil
Subscribe for More Information
December 15, 2014
09:03 EDTBAXBaxter to divest Vero cell vaccines platform to Nanotherapeutics
Baxter International (BAX) announced that it has entered into a definitive agreement to sell its proprietary Vero cell technology and related assets, including its production facility in Bohumil, Czech Republic, to Nanotherapeutics, Inc. Financial details were not disclosed. The agreement with Nanotherapeutics includes all assets related to the platform, including vaccines for H5N1, H1N1 and seasonal influenza. The agreement also includes investigational vaccine programs for Ross River virus, Chikungunya disease and West Nile virus. In recent weeks, the company has also completed the sale of its commercial vaccines business and related manufacturing facilities to Pfizer (PFE).
December 12, 2014
13:52 EDTUNHLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
13:05 EDTBHIBaker Hughes reports U.S. rig count down 27 to 1893
Baker Hughes reported the U.S. rig count is down 27 rigs from last week to 1893, with oil rigs down 29 to 1546, gas rigs up 2 to 346, and miscellaneous rigs unchanged at 1.
09:16 EDTDHRDanaher price target raised to $93 from $85 at RW Baird
Subscribe for More Information
08:21 EDTSAPMarketo doing more business with SAP, says JMP Securities
Subscribe for More Information
07:19 EDTDHRDanaher priced target raised to $94 from $88 at BofA/Merrill
Subscribe for More Information
December 11, 2014
06:04 EDTDHRDanaher sees FY15 adjusted EPS $4.35-$4.45, consensus $4.01
Subscribe for More Information
06:02 EDTDHRDanaher backs Q4 EPS view of $1.00-$1.04, consensus $1.02
December 10, 2014
17:19 EDTBAXBaxter announces filing of Form 10 in connection with planned spin-off
Subscribe for More Information
14:45 EDTUNHDeal would block payments to health insurance companies, The Hill says
Subscribe for More Information
09:53 EDTPMPhilip Morris says Chairman Louis Camilleri to retire on December 31
The company announces that Louis C. Camilleri, Chairman of the Board, will retire from employment with the company on December 31, 2014. Thereafter, Mr. Camilleri will serve as a non-employee Chairman of the Board. In this capacity, Camilleri will continue unchanged his role of facilitating communication between the Board of Directors and management, assisting the CEO in matters of long-term business strategy, and presiding at Shareholder and Board meetings. Thus, Camilleriís retirement will not affect his leadership role as Chairman of the Board, and it will preserve his earned pension benefits at present levels which would otherwise be reduced under the companyís pension formula.
December 9, 2014
13:45 EDTDHRDanaher to host investor and analyst meeting
Subscribe for More Information
12:22 EDTBAXPiper Jaffray biopharm analyst holds an analyst/industry conference call
Senior Research Analyst Schimmer, along with Biopharmaceuticals Analyst Breazzano, discuss gene therapy for hemophilia on an Analyst/Industry conference call to be held on December 11 at 10 am.
December 8, 2014
10:00 EDTPMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:10 EDTPMPhilip Morris downgraded to Reduce from Neutral at Nomura
Subscribe for More Information
07:53 EDTDHRDanaher price target raised to $100 from $89 at Jefferies
Jefferies raised its price target for Danaher shares to $100 ahead of the company's investor day and keeps a Buy rating on the name. It expects an initial 2015 organic growth outlook of 3% and earnings guidance of $3.95 and ex-amortization $4.40. Jefferies keeps a Buy rating on the stock.
07:30 EDTSAPSAP CEO sees company remaining independent for long-term, Reuters reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use